We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6762:TSETDK Corporation Analysis

Data as of 2026-06-12 - not real-time

¥3,504.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

TDK Corporation is trading above its short‑term moving averages, indicating momentum remains in its favor. The short‑term SMA sits below the current price while the medium‑term SMA also remains supportive, reinforcing a bullish technical backdrop. However, the MACD histogram has turned negative and the signal line is bearish, suggesting short‑term pressure may be building. RSI hovers around the mid‑range, implying neither overbought nor oversold conditions. Volume has been trending upward, confirming that market participants are actively trading the stock.
On the fundamentals side, revenue is expanding at a robust pace and margins are stable, supporting earnings growth. Cash generation is strong, with operating cash flow comfortably covering debt and enabling a healthy dividend payout. The dividend yield is modest with a payout ratio well below half, indicating sustainability. Valuation metrics place the share slightly above its discounted cash‑flow estimate, rendering it marginally overvalued at current levels. The recent announcement of a public buyout offer for a subsidiary could provide a catalyst, but integration risk remains. Overall, the stock presents a blend of growth and value attributes, with a moderate risk profile given sector volatility and global exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price above short‑term SMAs
  • bearish MACD histogram
  • rising volume suggests potential pullback

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • strong revenue growth
  • robust cash flow generation
  • reasonable valuation relative to peers

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • diversified product portfolio across multiple end‑markets
  • global footprint reduces concentration risk
  • sustainable dividend supports total return

Key Metrics & Analysis

Financial Health

Revenue Growth21.00%
Profit Margin7.81%
P/E Ratio34.0
ROE9.92%
ROA4.28%
Debt/Equity27.95
P/B Ratio3.0
Op. Cash Flow¥507.7B
Free Cash Flow¥35.0B
Industry P/E36.5

Technical Analysis

TrendBullish
RSI51.3
Support¥2,836.00
Resistance¥4,315.00
MA 20¥3,624.50
MA 50¥2,963.67
MA 200¥2,402.54
MACDBearish
VolumeIncreasing
Fear & Greed Index88.16

Valuation

Fair Value¥686.23
Target Price¥3,260.00
Upside/Downside-6.96%
GradeOvervalued
TypeBlend
Dividend Yield1.12%

Risk Assessment

Beta0.89
Volatility72.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.